NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia

PLoS One. 2021 Jul 7;16(7):e0254184. doi: 10.1371/journal.pone.0254184. eCollection 2021.

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy with few available targeted therapies. We previously reported that the phosphatase calcineurin (Cn) is required for LIC (leukemia Initiating Capacity) potential of T-ALL pointing to Cn as an interesting therapeutic target. Calcineurin inhibitors have however unwanted side effect. NFAT transcription factors play crucial roles downstream of calcineurin during thymocyte development, T cell differentiation, activation and anergy. Here we elucidate NFAT functional relevance in T-ALL. Using murine T-ALL models in which Nfat genes can be inactivated either singly or in combination, we show that NFATs are required for T-ALL LIC potential and essential to survival, proliferation and migration of T-ALL cells. We also demonstrate that Nfat genes are functionally redundant in T-ALL and identified a node of genes commonly deregulated upon Cn or NFAT inactivation, which may serve as future candidate targets for T-ALL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcineurin / metabolism
  • Calcineurin Inhibitors / pharmacology
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Cell Proliferation / drug effects
  • Cell Proliferation / physiology
  • Cell Survival / drug effects
  • Cell Survival / physiology
  • Cells, Cultured
  • Lymphocyte Activation / drug effects
  • Lymphocyte Activation / physiology
  • Mice
  • Mice, Inbred C57BL
  • NFATC Transcription Factors / metabolism*
  • NIH 3T3 Cells
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / metabolism*

Substances

  • Calcineurin Inhibitors
  • NFATC Transcription Factors
  • Calcineurin

Associated data

  • Dryad/10.5061/dryad.xd2547dfk

Grants and funding

This work was supported by funds from Institut Curie, Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM), Ligue contre le Cancer and Fondation ARC pour la recherche contre le cancer. CC, DP and SG were supported by pre-doctoral fellowships from the University Paris-Diderot and Ligue Nationale Contre le Cancer.